1 – 10 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Precision prognostics for cardiovascular disease in Type 2 diabetes : a systematic review and meta-analysis
(
- Contribution to journal › Article
- 2020
-
Mark
Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality : a prospective study
(
- Contribution to journal › Article
-
Mark
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
(
- Contribution to journal › Article
-
Mark
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis : A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Kv1.3 Channel, a Targetable Piece in the Complex Jigsaw Puzzle of Vascular Calcification?
(
- Contribution to journal › Debate/Note/Editorial
- 2018
-
Mark
MicroRNA-dependent regulation of KLF4 by glucose in vascular smooth muscle
(
- Contribution to journal › Article
- 2016
-
Mark
Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.
(
- Contribution to journal › Article
-
Mark
Elevated glucose levels promote contractile and cytoskeletal gene expression in vascular smooth muscle via Rho/protein kinase C and actin polymerization.
(
- Contribution to journal › Article
- 2015
-
Mark
Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
(
- Contribution to journal › Article
-
Mark
High glucose enhances store-operated calcium entry by upregulating ORAI/STIM via calcineurin-NFAT signalling
(
- Contribution to journal › Article